216 related articles for article (PubMed ID: 7529011)
21. Purification and characterization of HIV-1 reverse transcriptase having a 1:1 ratio of p66 and p51 subunits.
Stahlhut M; Li Y; Condra JH; Fu J; Gotlib L; Graham DJ; Olsen DB
Protein Expr Purif; 1994 Dec; 5(6):614-21. PubMed ID: 7532052
[TBL] [Abstract][Full Text] [Related]
22. Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stability.
Figueiredo A; Zelina S; Sluis-Cremer N; Tachedjian G
Curr HIV Res; 2008 Mar; 6(2):130-7. PubMed ID: 18336260
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
[TBL] [Abstract][Full Text] [Related]
24. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
25. TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: recent progress.
Camarasa MJ; Velázquez S; San-Félix A; Pérez-Pérez MJ; Bonache MC; De Castro S
Curr Pharm Des; 2006; 12(15):1895-907. PubMed ID: 16724955
[TBL] [Abstract][Full Text] [Related]
26. Reconstitution and properties of homologous and chimeric HIV-1.HIV-2 p66.p51 reverse transcriptase.
Howard KJ; Frank KB; Sim IS; Le Grice SF
J Biol Chem; 1991 Dec; 266(34):23003-9. PubMed ID: 1720776
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
28. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
29. The beta7-beta8 loop of the p51 subunit in the heterodimeric (p66/p51) human immunodeficiency virus type 1 reverse transcriptase is essential for the catalytic function of the p66 subunit.
Pandey PK; Kaushik N; Talele TT; Yadav PN; Pandey VN
Biochemistry; 2001 Aug; 40(32):9505-12. PubMed ID: 11583149
[TBL] [Abstract][Full Text] [Related]
30. 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.
Larder BA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2664-9. PubMed ID: 1282792
[TBL] [Abstract][Full Text] [Related]
31. The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.
Emini EA; Byrnes VW; Condra JH; Schleif WA; Sardana VV
Arch Virol Suppl; 1994; 9():11-7. PubMed ID: 7518271
[TBL] [Abstract][Full Text] [Related]
32. Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.
Ding J; Das K; Tantillo C; Zhang W; Clark AD; Jessen S; Lu X; Hsiou Y; Jacobo-Molina A; Andries K
Structure; 1995 Apr; 3(4):365-79. PubMed ID: 7542140
[TBL] [Abstract][Full Text] [Related]
33. Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor.
Isaka Y; Sato A; Kawauchi S; Suyama A; Miki S; Hayami M; Fujiwara T
Microbiol Immunol; 1998; 42(3):195-202. PubMed ID: 9570285
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase.
Kleim JP; Bender R; Kirsch R; Meichsner C; Paessens A; Riess G
Virology; 1994 May; 200(2):696-701. PubMed ID: 7513921
[TBL] [Abstract][Full Text] [Related]
35. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
Sardana VV; Emini EA; Gotlib L; Graham DJ; Lineberger DW; Long WJ; Schlabach AJ; Wolfgang JA; Condra JH
J Biol Chem; 1992 Sep; 267(25):17526-30. PubMed ID: 1381350
[TBL] [Abstract][Full Text] [Related]
37. Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits.
Amacker M; Hottiger M; Hübscher U
J Virol; 1995 Oct; 69(10):6273-9. PubMed ID: 7545246
[TBL] [Abstract][Full Text] [Related]
38. Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.
Balzarini J; Karlsson A; Pérez-Pérez MJ; Camarasa MJ; De Clercq E
Virology; 1993 Oct; 196(2):576-85. PubMed ID: 7690501
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of (138 Glu-->Lys) mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) to HIV-1-specific RT inhibitors.
Balzarini J; Kleim JP; Riess G; Camarasa MJ; De Clercq E; Karlsson A
Biochem Biophys Res Commun; 1994 Jun; 201(3):1305-12. PubMed ID: 7517668
[TBL] [Abstract][Full Text] [Related]
40. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC
J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
